To include your compound in the COVID-19 Resource Center, submit it here.

Abbott's rebound relationship

If Abbott Laboratories had succeeded last year in its attempted acquisition of Alza Corp., it would have added a strong presence in the drug delivery and urology markets. But that effort failed after ABT and AZA (Mountain View, Calif.) failed

Read the full 401 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers